New Search

Export article
Open Access

Genomic and epigenomic insights into the origin, pathogenesis, and clinical behavior of mantle cell lymphoma subtypes

, David Martin-Garcia, Guillem Clot, Ander Díaz-Navarro, Martí Duran-Ferrer, Alba Navarro, Roser Vilarrasa-Blasi, Marta Kulis, Romina Royo, Jesús Gutiérrez-Abril, Rafael Valdés-Mas, , Vicente Chapaprieta, , , Dolors Costa, Marta Aymerich, Pedro Jares, , Ana Muntañola, Inmaculada Ribera-Cortada, Reiner Siebert, Dolors Colomer, David Torrents, Eva Gine, Armando López-Guillermo, , Jose I. Martin-Subero, , ,
Published: 17 September 2020
 in Blood
Blood , Volume 136, pp 1419-1432; doi:10.1182/blood.2020005289

Abstract: Mantle cell lymphoma (MCL) is a mature B-cell neoplasm initially driven by CCND1 rearrangement with 2 molecular subtypes, conventional MCL (cMCL) and leukemic non-nodal MCL (nnMCL), that differ in their clinicobiological behavior. To identify the genetic and epigenetic alterations determining this diversity, we used whole-genome (n = 61) and exome (n = 21) sequencing (74% cMCL, 26% nnMCL) combined with transcriptome and DNA methylation profiles in the context of 5 MCL reference epigenomes. We identified that open and active chromatin at the major translocation cluster locus might facilitate the t(11;14)(q13;32), which modifies the 3-dimensional structure of the involved regions. This translocation is mainly acquired in precursor B cells mediated by recombination-activating genes in both MCL subtypes, whereas in 8% of cases the translocation occurs in mature B cells mediated by activation-induced cytidine deaminase. We identified novel recurrent MCL drivers, including CDKN1B, SAMHD1, BCOR, SYNE1, HNRNPH1, SMARCB1, and DAZAP1. Complex structural alterations emerge as a relevant early oncogenic mechanism in MCL, targeting key driver genes. Breakage-fusion-bridge cycles and translocations activated oncogenes (BMI1, MIR17HG, TERT, MYC, and MYCN), generating gene amplifications and remodeling regulatory regions. cMCL carried significant higher numbers of structural variants, copy number alterations, and driver changes than nnMCL, with exclusive alterations of ATM in cMCL, whereas TP53 and TERT alterations were slightly enriched in nnMCL. Several drivers had prognostic impact, but only TP53 and MYC aberrations added value independently of genomic complexity. An increasing genomic complexity, together with the presence of breakage-fusion-bridge cycles and high DNA methylation changes related to the proliferative cell history, defines patients with different clinical evolution.
Keywords: Behavior / copy number / diversity / epigenetic / structural / Cmcl / Bridge Cycles / Fusion Bridge / nnMCL

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

Share this article

Click here to see the statistics on "Blood" .
References (61)
    Cited by 12 articles
      Back to Top Top